User contributions for Apothequery
A user with 32 edits. Account created on 14 June 2018.
8 May 2019
- 12:4912:49, 8 May 2019 diff hist +380 m P-glycoprotein Added duloxetine as a potential PGP inhibitor in Drug Interaction paragraph Tag: Visual edit
25 April 2019
- 13:1913:19, 25 April 2019 diff hist +44 Rivaroxaban Edited sentence on generic availability since there is no guarantee that a generic will be made available immediately upon patent expiration Tag: Visual edit
24 April 2019
- 01:2701:27, 24 April 2019 diff hist +1,474 Rivaroxaban Fixed information in Introduction regarding generic availability; Added sentence on avoiding use with combined CYP3A4/PGP inhibitors; added specifics (dose-dependent and food-dependent) to bioavailability sentence; added some links to other wiki pages where appropriate Tag: Visual edit
8 April 2019
- 13:1213:12, 8 April 2019 diff hist +139 Vorinostat Edited preclinical investigations to accurately describe vorinostat status as a potential HIV treatment; added some links to other keywords in the preclinical investigation section Tag: Visual edit
23 March 2019
- 19:0519:05, 23 March 2019 diff hist +2,201 Disulfiram →Research: Edited and expanded the paragraph on research into disulfiram as an HIV latency reversal agent with more up-to-date trial citations Tag: Visual edit
22 January 2019
- 14:5514:55, 22 January 2019 diff hist +140 Plazomicin Updated approval information to past tense (because it seems that sentence was written before June 2018) and removed out-of-date phase III information with up-to-date approval information (with citation) Tag: Visual edit
15 January 2019
- 15:2315:23, 15 January 2019 diff hist +111 m Mavatrep Undid revision 878549469 by Apothequery (talk) Tag: Undo
- 13:3213:32, 15 January 2019 diff hist −111 Mavatrep Removed template stating that article did not have any categories because it now has three categories (drug, ion channel blockers, analgesics) Tag: Visual edit
- 13:3113:31, 15 January 2019 diff hist −110 m Mavatrep Removed unsuccessful attempt to add categories (including TPRV blocker) to the bottom of the article Tag: Visual edit
- 13:3013:30, 15 January 2019 diff hist +27 Template:Transient receptor potential channel modulators Added mavatrep to list of TPRV 1 blockers
- 13:2813:28, 15 January 2019 diff hist +429 Mavatrep Added drug bank number, inserted a couple more links to other wiki articles, added some categories Tags: nowiki added Visual edit
14 January 2019
- 15:0515:05, 14 January 2019 diff hist +18 m Mavatrep Added references heading Tag: Visual edit
- 15:0515:05, 14 January 2019 diff hist +2,182 N Mavatrep Created a small entry for mavatrep, an investigational drug for which two phase I studies have recently published results. The small entry includes some introductory information and some scarce PK information. Tag: Visual edit
- 14:4214:42, 14 January 2019 diff hist +4 m List of investigational analgesics Added hyper-link to mavatrep Tag: Visual edit
- 14:0214:02, 14 January 2019 diff hist +1,354 List of investigational analgesics Added Mavatrep (JNJ‐39439335) – TRPV1 antagonist to list of TRP channel modulators with reference to two recent phase I trials Tag: Visual edit
30 November 2018
- 14:0614:06, 30 November 2018 diff hist +674 P-glycoprotein →Drug interactions: Added more P-gp inducers to drug interaction paragraph Tag: Visual edit
- 13:5313:53, 30 November 2018 diff hist +396 m CYP3A4 →CYP3A4 ligands: Added phenytoin to list of strong inducers with source Tag: Visual edit
- 13:3713:37, 30 November 2018 diff hist +436 m P-glycoprotein →Drug interactions: Added reserpine and dabigatran to drug interaction paragraph Tag: Visual edit
- 13:2913:29, 30 November 2018 diff hist +744 P-glycoprotein Edited the drug interactions paragraph by adding ketoconazole and saquinavir to the list of P-gp inhibitors. Also added common inducers and substrates. Tag: Visual edit
8 November 2018
- 15:3015:30, 8 November 2018 diff hist +156 m CYP3A4 Added miconazole (moderate CYP3A4 inhibitor) to table with citation Tag: Visual edit
26 October 2018
- 19:2419:24, 26 October 2018 diff hist +45 User:Apothequery Added additional credential current Tag: Visual edit
- 19:0919:09, 26 October 2018 diff hist +886 Blinatumomab Added a few details to medical use, mechanism of action, and cost. Updated package insert from 2014 version to 5/2018 version Tag: Visual edit
5 October 2018
- 12:5412:54, 5 October 2018 diff hist +369 Tamoxifen Added available formulations (oral tablet and oral solution) to the definition paragraph Tag: Visual edit
4 October 2018
- 15:0515:05, 4 October 2018 diff hist +1,017 Paclitaxel Small changes in introduction regarding formulations and indications Tag: Visual edit
19 September 2018
- 19:2119:21, 19 September 2018 diff hist +264 Bisphosphonate Added a sentence to Pharmacokinetics section with information on bsiphosphonate half life in bone tissue Tag: Visual edit
14 September 2018
- 15:5515:55, 14 September 2018 diff hist +1,190 Lenalidomide Added some basic information from most recent FDA label (2017), added an indication (refractory mantle cell lymphoma) which had previously been missing Tag: Visual edit
9 August 2018
- 13:3513:35, 9 August 2018 diff hist +551 m Bosentan Replaced bioavailability citation with a more primary source Tag: Visual edit
- 13:2113:21, 9 August 2018 diff hist +326 Wikipedia:Changing username/Simple No edit summary
- 13:1213:12, 9 August 2018 diff hist +2,344 Bosentan Updated information from FDA labeling with most recent package insert. Added how bosentan is available (oral tablets and dispersable tablets for oral suspension) and a small pharmacokinetics section. Tags: nowiki added Visual edit
6 August 2018
- 12:5212:52, 6 August 2018 diff hist +622 CYP3A4 Added some items to CYP3A4 inhibitor list, clarified strength of some inhibitors and cited source Tag: Visual edit
14 June 2018
- 19:0319:03, 14 June 2018 diff hist +134 N User:Apothequery added a brief description Tag: Visual edit
- 19:0019:00, 14 June 2018 diff hist +4,171 Furosemide Added more pharmacokinetic information, added sources to existing pharmacokinetic information Tag: Visual edit
